ClinicalTrials.gov
public full text
Public Domain
MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors#234428
- Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer#833262
- Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer#915109
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL#888448
- Siglec-15 is a glyco-immune checkpoint in prostate cancer regulating immune evasion and metastasis#668726
Record · ID 162445
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive